Emergence of IMP-34- and OXA-58-Producing Carbapenem-Resistant Acinetobacter colistiniresistens

Antimicrob Agents Chemother. 2019 May 24;63(6):e02633-18. doi: 10.1128/AAC.02633-18. Print 2019 Jun.

Authors

Yuki Suzuki^#^{1

2}, Shiro Endo^#^{1

3}, Ryuichi Nakano⁴, Akiyo Nakano², Kyoichi Saito^{1

2}, Risako Kakuta¹, Naoki Kakuta², Saori Horiuchi², Hisakazu Yano², Mitsuo Kaku¹

Affiliations

¹ Department of Infection Control and Laboratory Diagnosis, Internal Medicine, Tohoku University Graduate School of Medicine, Miyagi, Japan.
² Department of Microbiology and Infectious Diseases, Nara Medical University, Nara, Japan.
³ International University of Health and Welfare, Shioya Hospital, Tochigi, Japan.
⁴ Department of Microbiology and Infectious Diseases, Nara Medical University, Nara, Japan rnakano@naramed-u.ac.jp.

^# Contributed equally.

No abstract available

Keywords: Acinetobacter colistiniresistens; IMP-34; OXA-58; colistin resistance.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Acinetobacter / drug effects*
Anti-Bacterial Agents / pharmacology*
Carbapenems / pharmacology*

Substances

Anti-Bacterial Agents
Carbapenems

Supplementary concepts

Acinetobacter colistiniresistens